home / stock / hkmpf / hkmpf quote
Last: | $22.33 |
---|---|
Change Percent: | 0.0% |
Open: | $0 |
Close: | $22.33 |
High: | $0 |
Low: | $0 |
Volume: | 1 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$22.33 | $0 | $22.33 | $0 | $0 | 1 | 05-01-2024 |
$22.33 | $22.33 | $22.33 | $22.33 | $22.33 | 204 | 04-17-2024 |
$24.25 | $0 | $24.25 | $0 | $0 | 946 | 04-16-2024 |
$24.25 | $0 | $24.25 | $0 | $0 | 3 | 04-15-2024 |
$24.25 | $0 | $24.25 | $0 | $0 | 2 | 04-10-2024 |
$24.25 | $0 | $24.25 | $0 | $0 | 15 | 04-05-2024 |
$24.25 | $0 | $24.25 | $0 | $0 | 8 | 04-03-2024 |
$24.25 | $24.25 | $24.25 | $24.25 | $24.25 | 1,723 | 04-01-2024 |
$22.9 | $0 | $22.9 | $0 | $0 | 70 | 03-26-2024 |
$22.9 | $0 | $22.9 | $0 | $0 | 3 | 03-25-2024 |
$22.9 | $0 | $22.9 | $0 | $0 | 946 | 03-20-2024 |
$23.37 | $23.37 | $23.37 | $23.37 | $23.37 | 166 | 03-07-2024 |
$24.1 | $24.1 | $24.1 | $24.1 | $24.1 | 1,001 | 03-06-2024 |
$24.32 | $24.32 | $24.32 | $24.32 | $24.32 | 200 | 02-29-2024 |
$26.5 | $0 | $26.5 | $0 | $0 | 3 | 02-28-2024 |
$26.5 | $26 | $26.5 | $26.5 | $26 | 1,104 | 02-22-2024 |
$25 | $0 | $25 | $0 | $0 | 72 | 02-16-2024 |
$25 | $25 | $25 | $25 | $25 | 328 | 02-15-2024 |
$24.33 | $24.33 | $24.33 | $24.33 | $24.33 | 115 | 02-14-2024 |
$24.02 | $0 | $24.02 | $0 | $0 | 1,100 | 02-09-2024 |
News, Short Squeeze, Breakout and More Instantly...
Hikma Pharmaceuticals Plc Company Name:
HKMPF Stock Symbol:
OTCMKTS Market:
Hikma confirms that it has not signed a licensing agreement with Opiant Pharmaceuticals Canada NewsWire LONDON , April 29, 2022 /CNW/ -- Hikma Pharmaceuticals PLC (Hikma) confirms that it has not entered into any transaction with Opiant Pharmaceuticals, contrary ...
Hikma resumes launch of generic Advair Diskus® PR Newswire LONDON , April 20, 2021 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that it has resumed the launch of its generic version of ...
LONDON , Sept. 3, 2020 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that the US Court of Appeals for the Federal Circuit today upheld a ruling by the US District Court for the District of Nevada finding that Hikma's gen...